86 related articles for article (PubMed ID: 9680059)
1. Conformational sampling of bioactive conformers: a low-temperature NMR study of 15N-Leu-enkephalin.
Amodeo P; Naider F; Picone D; Tancredi T; Temussi PA
J Pept Sci; 1998 Jun; 4(4):253-65. PubMed ID: 9680059
[TBL] [Abstract][Full Text] [Related]
2. Theoretical study of the flexibility and solution conformation of the cyclic opioid peptides [D-Pen2,D-Pen5]enkephalin and [D-Pen2,L-Pen5]enkephalin.
Chew C; Villar HO; Loew GH
Mol Pharmacol; 1991 Apr; 39(4):502-10. PubMed ID: 2017150
[TBL] [Abstract][Full Text] [Related]
3. Lipid-induced secondary structures and orientations of (Leu5)-enkephalin: helical and crystallographic double-bend conformers revealed by IRATR and molecular modelling.
Schwyzer R; Moutevelis-Minakakis P; Kimura S; Gremlich HU
J Pept Sci; 1997; 3(1):65-81. PubMed ID: 9230472
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of deltorphin I at 265 K: a quantitative NMR study.
Amodeo P; Motta A; Tancredi T; Salvadori S; Tomatis R; Picone D; Saviano G; Temussi PA
Pept Res; 1992; 5(1):48-55. PubMed ID: 1623303
[TBL] [Abstract][Full Text] [Related]
5. Dynamic space structure of the Leu-enkephalin molecule in DMSO solution.
Vesterman B; Saulitis J; Betins J; Liepins E; Nikiforovich GV
Biochim Biophys Acta; 1989 Oct; 998(2):204-9. PubMed ID: 2790063
[TBL] [Abstract][Full Text] [Related]
6. New theoretical methodology for elucidating the solution structure of peptides from NMR data. II. Free energy of dominant microstates of Leu-enkephalin and population-weighted average nuclear Overhauser effects intensities.
Meirovitch E; Meirovitch H
Biopolymers; 1996 Jan; 38(1):69-88. PubMed ID: 8679943
[TBL] [Abstract][Full Text] [Related]
7. The effect of conformation of the acyloxyalkoxy-based cyclic prodrugs of opioid peptides on their membrane permeability.
Gudmundsson OS; Vander Velde DG; Jois SD; Bak A; Siahaan TJ; Borchardt RT
J Pept Res; 1999 Apr; 53(4):403-13. PubMed ID: 10406218
[TBL] [Abstract][Full Text] [Related]
8. Conformational preferences of [Leu5]enkephalin in biomimetic media. Investigation by 1H NMR.
Picone D; D'Ursi A; Motta A; Tancredi T; Temussi PA
Eur J Biochem; 1990 Sep; 192(2):433-9. PubMed ID: 2209598
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and conformational studies of a beta-turn mimetic incorporated in Leu-enkephalin.
Blomberg D; Hedenström M; Kreye P; Sethson I; Brickmann K; Kihlberg J
J Org Chem; 2004 May; 69(10):3500-8. PubMed ID: 15132562
[TBL] [Abstract][Full Text] [Related]
10. 15N spin-lattice relaxation study of linear peptides: preliminary results on Leu-enkephalin and Tyr-Gly-Gly-Phe.
Marion D; Garbay-Jaureguiberry C; Roques BP
Biochem Biophys Res Commun; 1981 Aug; 101(3):711-8. PubMed ID: 7306111
[No Abstract] [Full Text] [Related]
11. Solution conformation of [D-Pen2, D-Pen5] enkephalin in water: a NMR and molecular dynamics study.
Gussmann M; Borsdorf R; Hofmann HJ
J Pept Sci; 1996; 2(6):351-6. PubMed ID: 9230462
[TBL] [Abstract][Full Text] [Related]
12. Evidence for effect of GM1 on opioid peptide conformation: NMR study on leucine enkephalin in ganglioside-containing isotropic phospholipid bicelles.
Gayen A; Mukhopadhyay C
Langmuir; 2008 May; 24(10):5422-32. PubMed ID: 18412380
[TBL] [Abstract][Full Text] [Related]
13. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
[TBL] [Abstract][Full Text] [Related]
14. The conformation of enkephalin bound to its receptor: an "elusive goal" becoming reality.
Sanfelice D; Temussi PA
Front Mol Biosci; 2014; 1():14. PubMed ID: 25988155
[TBL] [Abstract][Full Text] [Related]
15. 17O NMR and FT-IR study of the ionization state of peptides in aprotic solvents. Application to Leu-enkephalin.
Gerothanassis IP; Birlirakis N; Karayannis T; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Vitoux B; Marraud M
FEBS Lett; 1992 Feb; 298(2-3):188-90. PubMed ID: 1544442
[TBL] [Abstract][Full Text] [Related]
16. Structural and biological implications of the binding of Leu-enkephalin and its metal derivatives to opioid receptors.
Wieberneit F; Korste A; Albada HB; Metzler-Nolte N; Stoll R
Dalton Trans; 2013 Jul; 42(27):9799-802. PubMed ID: 23525213
[TBL] [Abstract][Full Text] [Related]
17. 17O- and 14N-NMR studies of Leu-enkephalin and enkephalin-related fragments in aqueous solution.
Karayannis T; Gerothanassis IP; Sakarellos-Daitsiotis M; Sakarellos C; Marraud M
Biopolymers; 1990 Feb; 29(2):423-39. PubMed ID: 2331506
[TBL] [Abstract][Full Text] [Related]
18. Fine refinement of solid-state molecular structures of Leu- and Met-enkephalins by NMR crystallography.
Pawlak T; Potrzebowski MJ
J Phys Chem B; 2014 Mar; 118(12):3298-309. PubMed ID: 24605867
[TBL] [Abstract][Full Text] [Related]
19. Conformational analysis of cyclic partially modified retro-inverso enkephalin analogues by proton NMR.
Mammi NJ; Goodman M
Biochemistry; 1986 Nov; 25(23):7607-14. PubMed ID: 3801437
[TBL] [Abstract][Full Text] [Related]
20. Does a 2----5 beta-turn structure exist in enkephalins? Study of a fully protected Leu-enkephalin in organic solution by 17O-NMR.
Moret E; Gerothanassis IP; Hunston RN; Lauterwein J
FEBS Lett; 1990 Mar; 262(2):173-5. PubMed ID: 2335199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
